Supplementary Protection Certificate rules interpreted in different ways have left the EU’s generic and biosimilar industries hungry for clarity, explains Jiri Slavik of Adalvo. If you don't have a ...

Patent cliff: 5 blockbusters running out of road ...

With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster ...

Leading patent litigator who worked on disputes involving Broadcom, Sonos, and Tesla joins firm’s Düsseldorf office from EIP. Already registered?

11 March 2025 The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of ...

19 October 2023 Luxemboug court agrees with European Commission that ‘beneficial arrangement’ between Teva and Cephalon ...

Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees helped ProfoundBio use confidential tech to improve its cancer treatment ...

Court of Appeals rules defence costs in Hatch-Waxman cases are deductible as ordinary business expenses | US IRS stands to pay tax rebate to generics manufacturer.

Both parties write to district court hours after Court of Appeals denies rehearing | MSN maintains that the Entresto patent ...

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...